Besides the stability regulation, HIF-1α protein synthesis can be activated in cancer cells through the phosphatidylinositol-3-kinase (PI3K)–Akt signaling axis primarily by the action of mammalian target of rapamycin complex 1 (mTORC1) [20, 21]. This evidence concerns the gene HIF1A and cancer.